Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children
Open Access
- 1 March 1998
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 351 (9104) , 709-713
- https://doi.org/10.1016/s0140-6736(97)09222-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infantsThe Lancet, 1997
- Atovaquone and Proguanil for the Treatment of Malaria in BrazilThe Journal of Infectious Diseases, 1997
- Atovaquone for Salvage Treatment and Suppression of Toxoplasmic Encephalitis in Patients with AIDSClinical Infectious Diseases, 1997
- Atovaquone and proguanil for Plasmodium falciparum malariaThe Lancet, 1996
- Clinical Studies of Atovaquone, Alone or in Combination with other Antimalarial Drugs, for Treatment of Acute Uncomplicated Malaria in ThailandThe American Journal of Tropical Medicine and Hygiene, 1996
- Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in ZaireTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- Interactions of Atovaquone with Other Antimalarial Drugs against Plasmodium falciparum in VitroExperimental Parasitology, 1995
- Comparison of Atovaquone (566C80) with Trimethoprim-Sulfamethoxazole to Treat Pneumocystis carinii Pneumonia in Patients with AIDSNew England Journal of Medicine, 1993
- Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3- hydroxy-1,4-naphthoquinone (566C80)Biochemical Pharmacology, 1992
- The Effect of Lapinone (M-2350) on P. Vivax Infection in ManThe American Journal of Tropical Medicine, 1951